CBS News published an investigation this week into the booming gray market for retatrutide — an expe...
The Texas Board of Pharmacy on Wednesday finally passed its updated rules for compounding. If you li...
Even pharmacists can lose an initialism or acronym or two in a metaphorical bowl of alphabet soup. T...
Sara Talpos’s article about peptides in Undark (and also published in Stat News) might be the most t...
There’s good news on the drug-shortages front, according to the latest report from the American Soci...
HHS’s Office of the Inspector General has issued a new advisory bulletin about pharma manufacturers ...
With patents for semaglutide expiring in the not-too-distant future, Novo Nordisk is pulling out all...
According to a ProPublica analysis, “the FDA has lost more than 400 workers who support inspections ...
Number 6 will blow your mind! We just love* the clickbait headline from Everyday Health: “9 Signs Yo...
Running for the board? If you’re thinking about running for the 2025–26 APC Board of Directors, don’...